ClinicalTrials.gg
CompletedNCT04667767TISAUpdated Jan 25, 2024

The TISA Trial - Senegal

An interventional study of WASH kit and Standard treatment in Severe Acute Malnutrition, sponsored by London School of Hygiene and Tropical Medicine. Completed at 1 site in Senegal. Open to participants aged 6 Months to 59 Months. Per ClinicalTrials.gov, last updated 2024-01-25.

Sponsored by London School of Hygiene and Tropical Medicine · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
2,411
Allocation
Randomized
Ages
6 Months to 59 Months
Sex
All
01

Study summary

This study evaluates the addition of a simple, scalable "WASH kit", including household water treatment products, a safe water storage container, and hygiene promotion, to the standard national protocol for outpatient treatment of uncomplicated severe acute malnutrition among children aged 6-59 months of age in northern Senegal.

Read the detailed description

Severe acute malnutrition (SAM) is defined as a weight-for-height z-score (WHZ) below -3 of the World Health Organisation growth standards. It is a short-term acute condition with a high case-fatality rate that increases both the susceptibility of children to infection and the risk of mortality. The global prevalence of SAM in children is estimated to be over 17 million with most of those affected living in sub-Saharan Africa and Asia.

Community-Based Management of Acute Malnutrition (CMAM) has significantly changed standard practice for the treatment of SAM. Uncomplicated SAM cases are now predominantly managed on an outpatient basis and Action Contre la Faim (ACF) supports outpatient treatment programs (OTP) across the globe, particularly in Africa and Asia. This innovation has increased coverage, and reduced the cost of treatment for both the health system and individuals. However, under CMAM, the treatment context has moved from a more controlled health facility setting to the generally less controlled household setting where the risk of infection due to environmental hazards, such as contaminated water, may be higher.

The TISA trial described here will evaluate the effectiveness of combining a simple, scalable "WASH kit" with OTP on the recovery rate among uncomplicated SAM cases aged 6-59 compared to the national standard OTP. The WASH kit includes a plastic container, a supply of Aquatabs® (effervescent chlorine tablets), and training in their use and associated hygiene practices. The study is a cluster randomized controlled trial (cRCT), with health centres constituting the clusters. Clusters are randomly allocated to either a control group receiving the standard OTP or an intervention group receiving OTP plus the WASH kit. The primary outcome of the trial is the recovery rate and the secondary outcomes are weight gain, referral rate, longitudinal prevalence of diarrhoea, prevalence of enteric pathogen detection and all-cause mortality.

02

Conditions studied

  • Severe Acute Malnutrition
03

In context

Severe Acute Malnutrition

82 studies on the registry are indexed under Severe Acute Malnutrition; 13 are open to participants now.

This study's enrollment of 2,411 is above the median of 400 across 69 interventional studies indexed under Severe Acute Malnutrition.

Browse Severe Acute Malnutrition studies →

Lead sponsor

London School of Hygiene and Tropical Medicine is the lead sponsor of 298 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 59 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Weight-for-height z-score \<-3; or
  • Brachial perimeter (mid-upper arm circumference) \<115; or
  • Bilateral oedema

Exclusion criteria

Exclusion Criteria:

  • Not able and/or willing to participate for up to 8-weeks
  • Clinical complications requiring referral and/or inpatient treatment
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,411 participants (actual)

Study arms

  • Experimental
    Intervention

    In addition to the national standard outpatient treatment for uncomplicated severe acute malnutrition, caregivers of participants will receive a "WASH kit" containing a plastic container, a supply of Aquatabs® (effervescent chlorine tablets), and training in their use and associated hygiene practices.

    Other: WASH kit

  • Active comparator
    Control

    National standard outpatient treatment for uncomplicated severe acute malnutrition

    Other: Standard treatment

Interventions

  • OtherWASH kit

    WASH kit containing a plastic container and a supply of Aquatabs® (effervescent chlorine tablets) and training in their use and associated hygiene practices.

  • OtherStandard treatment

    National standard outpatient treatment for uncomplicated severe acute malnutrition

06

What researchers measure

Primary outcomes

  1. Rate of recovery

    Recovery defined as two consecutive weeks with weight-for-height z-scores ≥ -1.5, if admitted based on weight-for-height z-score, or brachial perimeter (mid-upper arm circumference) ≥ 125 mm, if admitted based on brachial perimeter, and no oedema.

    Time frame: 8 weeks

Secondary outcomes

  1. Weight gain

    Weight gain defined as grams of weight gained per kilogram per day between entry and exit.

    Time frame: 8 weeks

  2. Rate of referral

    Referral rate defined as number of participants referred/transferred to next level of care.

    Time frame: 8 weeks

  3. Longitudinal prevalence of diarrhoea

    Longitudinal prevalence is defined by weeks with diarrhoea during follow-up with diarrhoea defined according to WHO definition (3 or more loose or liquid stools passed within 24 hours).

    Time frame: 8 weeks

  4. Prevalence of enteric pathogen detection

    Enteric pathogen detection by stool-based molecular assays of following pathogens: Adenovirus F(40/41), Astrovirus, Norovirus GI, Norovirus GII, Rotavirus, Sapovirus, Enteroaggregative E. coli (EAEC), Shiga-like toxin producing E. coli (STEC), Enteropathogenic Escherichia coli (EPEC), Enterotoxigenic E. coli (ETEC), Shigella/ Enteroinvasive Escherichia coli (EIEC), Campylobacter jejuni/coli, Salmonella enterica, Salmonella enterica Typhi, Vibrio cholerae, Clostridioides difficile, Yersinia enterocolitica, E. coli O157, Aeromonas, Helicobacter pylori, Cryptosporidium spp., Giardia spp., Entamoeba histolytica, Ascaris lumbricoides, Trichuris trichiura, Ancylostoma duodenale, Necator americanus, Strongyloides stercolaris, Plesiomonas shigelloides, Shigella flexneri, Shigella sonnei, Cyclospora cayetanensis.

    Time frame: 8 weeks

  5. All cause mortality

    Deaths occurring during follow-up due to any cause.

    Time frame: 8 weeks

07

Study locations

1 site
  • ACF Senegal
    Louga, Senegal
08

References and documents

Individual participant data

Plan to share: Yes — All IPD that underlie results in a publication will be shared

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: December 2022

Access criteria: All IPD that underlie results will be made publicly available

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04667767
Collaborators
Action Contre la Faim, Cheikh Anta Diop University, Senegal
Responsible party
Sponsor
First posted
Dec 16, 2020
Start date
Dec 22, 2020
Primary completion
Apr 27, 2023
Completion
Apr 27, 2023
Last update
Jan 25, 2024

Study contacts

Oliver Cumming, MSc
principal investigator · London School of Hygiene and Tropical Medicine
Dieynaba N'Diaye, PhD
principal investigator · Action Contre La Faim - France
Moustapha Seye, PhD
principal investigator · Université Cheikh Anta Diop de Dakar

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion